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Sulfated polysaccharides (SPs) extracted from five seaweed samples collected or cultivated in Mexico (Macrocystis pyrifera, Eisenia
arborea, Pelvetia compressa, Ulva intestinalis, and Solieria filiformis) were tested in this study in order to evaluate their effect on
measles virus in vitro. All polysaccharides showed antiviral activity (as measured by the reduction of syncytia formation) and low
cytotoxicity (MTT assay) at inhibitory concentrations. SPs from Eisenia arborea and Solieria filiformis showed the highest antiviral
activities (confirmed by qPCR) and were selected to determine their combined effect. Their synergistic effect was observed at low
concentrations (0.0274𝜇g/mL and 0.011𝜇g/mL of E. arborea and S. filiformis SPs, resp.), which exhibited by far a higher inhibitory
effect (96% syncytia reduction) in comparison to the individual SP effects (50% inhibition with 0.275𝜇g/mL and 0.985 𝜇g/mL of
E. arborea and S. filiformis, resp.). Time of addition experiments and viral penetration assays suggest that best activities of these SPs
occur at different stages of infection. The synergistic effect would allow reducing the treatment dose and toxicity and minimizing
or delaying the induction of antiviral resistance; sulfated polysaccharides of the tested seaweed species thus appear as promising
candidates for the development of natural antiviral agents.
1. Introduction
LatinAmerica has an important and diverse group of seaweed
species [1]. Recent data on seaweed management in this
region have described the main harvest and aquaculture
taking place in Argentina, Brazil, Chile, Peru, andMexico [2].
One of the goals of seaweeds exploitation is to diversify their
application by screening their diverse bioactive compounds,
which remain unexplored in nutraceutical and pharmaceuti-
cal areas [3]. Different chemical compounds have been iso-
lated from algae, including polysaccharides, which have been
subjected to a variety of studies due to their extensive bioac-
tivities and applications [4].
An increasing number of biological activities of seaweed
polysaccharides have been reported in the last decades, where
sulfated polysaccharides (SPs) are among the most studied
compounds [5]. SPs include a complex group of macro-
molecules with numerous activities such as antioxidant [6, 7],
antitumor [8, 9], anticoagulant [6], anti-inflammatory [6, 10],
and antiviral [11, 12].
Antiviral activity of SPs was first reported in 1958 [13] and
over the years a substantial research has been focused on this
field. SP can be obtained from each of the three main classes
of seaweed: fucoidans and alginates from brown algal species,
agaroids and carrageenans from red macroalgae, and ulvans
from green seaweeds [14].
Fucoidans have shown a potent antiviral activity against
numerous enveloped viruses including herpes simplex virus
type 1 (HSV-1) [15], human immunodeficiency virus [16],
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influenza A virus [17], and different kind of paramyxoviruses
such as Newcastle disease virus (NDV) and canine distemper
virus (CDV) [18, 19]. In vitro and in vivo antiretroviral effects
of alginates preventing syncytium formation and reducing
the P24 core antigen level have been demonstrated [20].
Antiviral activity of carrageenans has been demonstrated in
vitro against human papillomavirus (HPV), acting mainly on
the inhibition ofHPV virions binding to cells, and also in vivo
by preventing infection by different HPV genotypes [21, 22].
Recently, antiviral activity against NDV of ulvan from Ulva
clathrata cultivated in Mexico has been reported [23].
Nowadays, combining multiple drugs is a primary
approach for improving antiviral effects within the antiviral
drug therapy field. The advantages of multidrugs combina-
tion are the reduction of individual drugs doses, a decrease in
the side effects of antiviral agents, and the prevention of drug-
resistant viruses emergence. Drug combination theories pro-
vide an ideal tool for this purpose to understand the benefits
of multidrugs combinations therapy [24].
Measles virus (MeV) belongs to the Paramyxoviridae
family of Mononegavirales, is a nonsegmented negative-
strand RNA virus, and causes a highly contagious disease
[25]. Although preventable by vaccination, measles still
remains one of the causes of death among young children
worldwide [26]. Many new antiviral drugs have been licensed
in recent years, most of which are used for the treatment of
HIV infections [27]. The investigation of natural antivirals
isolated frommarine sources is an interesting approach in the
development of new antiviral agents. In the present study, we
tested the antiviral activity of SPs isolated from five Mexican
seaweeds againstMeV.The aimof this researchwas to develop
new candidates of antiviral drugs that could help to control
viral infection diseases.
2. Materials and Methods
2.1. Antiviral Agents
2.1.1. Collection of Seaweed. Five species of macroalgae were
collected from the Mexican coasts and tested for this study:
three brown seaweeds from Baja California (Macrocystis
pyrifera, Eisenia arborea, and Pelvetia compressa), one green
seaweed from Southern Baja California (Ulva intestinalis),
and one red seaweed from Yucatan (Solieria filiformis).
Macrocystis pyrifera (Linnaeus) C. Agardh was collected
in Bahı´a de Ensenada (Manto Jantay) in front of the Sal-
sipuedes beach (31.983–116.815), in January 2013. Eisenia
arborea J. E. Areschoug and Pelvetia compressa (J. Agardh)
De Toni were collected in the Escalera Zone, North of Punta
China (31.520–116.650) in December 2014-January 2015. The
green algaUlva intestinalis (Linnaeus) was collected from the
water drainage channel of the Gran Mar shrimp farm, on the
Baja California West coast (24.434–111.584) in August 2014.
Solieria filiformis (Ku¨tzing) P. W. Gabrielson, a red sea-
weed considered as a potential source of 𝜄-carrageenan [28],
was obtained from an aquaculture facility at the Telchac
Marine station-CINVESTAV, Yucatan (Mexico), where it is
periodically cultivated in bimonthly cycles in semiopen tanks
as part of an Integrated Multitrophic aquaculture system.
The sample used came from a batch cultured from April to
May 2014.
Once harvested, the brown and green algae samples were
washed in seawater to eliminate sand, shells, and epibionts
and dried under shade, while the cultivated red algae was
washedwith freshwater and dried in an oven at 60∘C. Prior to
extraction, the samples were cut into small 2-3 cm pieces and
ground to pass through a 0.5mm sieve (Turbomolino Pulvex
200 mill).
2.1.2. Extraction and Purification of Sulfated Polysaccharides.
Polysaccharides extraction was performed after extraction of
polyphenols [29]. Briefly 10 g of alga powder was washedwith
distillated water and dried at room temperature overnight.
The washed powder was extracted with 200mL 50% v/v
ethanol and sonicated for 30min at room temperature,
followed with an extraction period in a bath shaker at
70∘C during 2 hours. The samples were centrifuged for
15min (2500 rpm).The pellet was used for the polysaccharide
extraction according to the procedure described by Tako et al.
2000 and Ale et al. 2012 [30, 31]. Briefly, 200mL of 0.1M HCl
was added to the algae pellet and heated for 1 hour at boiling
temperature and centrifuged at 3500 rpm for 10 minutes.
The supernatant was recovered and absolute ethanol was
added (4 : 1) for polysaccharides precipitation. Once precip-
itated, the polysaccharides were separated from the aqueous
medium by centrifugation at 3500 rpm for 10 minutes; the
supernatant was discarded and the pellet was washed three
times with 96% ethanol to remove residual pigments and
finally resuspended in a minimum amount of distilled water
for a 72-hour dialysis with stirring. The dialyzed product
was precipitated with absolute ethanol (4 : 1). Polysaccharide
extracts were lyophilized and weighed to calculate their yield.
2.1.3. Characterization of Selected Polysaccharide Extracts
(1) FT-IR Spectra Analysis. IR spectra of aqueous extracted
polysaccharides from Solieria filiformis and Eisenia arborea
were obtained using diffuse reflectance infrared Fourier
transform spectroscopy (DRIFTS). Scans were performed at
room temperature in the infrared region between 4000 and
400 cm−1 on a Thermo Nicolet Nexus 670 FT-IR spectrome-
ter.The infrared spectra of commercial available carrageenan
(𝜄-carrageenan C1138, 𝜅-carrageenan C1013), fucoidan from
Fucus vesiculosus (F5631), alginic acid (A7003) from Sigma-
Aldrich (St. Louis,MO,USA), and 𝜆-carrageenan fromCeltic
Colloids Inc. (B. Blakemore) were included for comparison.
(2) NMR Spectra Analysis. 13C-NMR spectra were acquired
on a Varian 600 spectrometer. The extracts were exchanged
twice with 99.8% deuterium oxide (D2O) with intermediate
lyophilization and dissolved at 10mgmL−1 in D2O. Sodium
[3-trimethylsilyl 2,2󸀠,3,3󸀠-2-H4] propionate (TSP-d4) was
used as an internal reference to 0.00 ppm.
(3) Carbohydrate Determination. For determination of total
sugars in the samples acid hydrolysis of the extracts was
performed. A solution with 25mg of polysaccharide extract
in 100mL of 1MH
2
SO
4
was prepared and boiled for 3 hours;
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subsequently, an aliquot of 1mL of each extract was taken.
Anthrone reagent (5mL) was added to the aliquot, placed in
a water bath for 12 minutes, and cooled down at room tem-
perature. Absorbance was read at 630 nm. Quantification was
performed against a calibration curve of a stock solution of
fucose.
(4) Sulfate Content Determination. The analysis was per-
formed using the turbidimetric method of Jackson and
McCandless, 1978 [32]. Briefly, this quantification of sulfates
was determined by measuring turbidity as barium sulfate
when adding 1.2mL of TCA 8% and 0.6mL of 0.01% reaction
reagent (agarose/barium chloride) to the sample; reaction
was homogenized by stirring for 35 minutes. The turbidity
was determined at 500 nm in a ShimadzuUV-Vis spectropho-
tometer 1601. The calibration curve was performed with
potassium sulfate (K
2
SO
4
) with a concentration of 0 to 100 𝜇g
of SO
4
−2/mL. SP extracts of Solieria filiformis and Eisenia
arboreawere weighed (7mg), and 1mL of 1N HCl was added
and heated at 105∘C for 12 hours in a thermoblock (Lab line).
A dilution was performed with 10mL of deionized water;
samples were then filtered using a microfilter with Whatman
paper of 1.2 𝜇m and an aliquot of 1.1mL of the samples was
taken for quantification.Analysiswas performedby triplicate.
2.2. Cells and Virus. Vero cells were grown at 37∘C in a
5% CO
2
atmosphere in Dulbecco’s Modified Eagle Medium
Nutrient Mixture F-12 (DMEM/F12, Gibco Invitrogen, USA)
supplemented with 5% fetal bovine serum (FBS, Gibco
Invitrogen, USA) and 1% antibiotic (Gibco Invitrogen, USA).
Measles virus (Edmonston strain) was purchased from
ATCC (ATCCVR-24). Virus was propagated onVero cells
and viral titers were determined by cytopathogenic effect and
expressed as 50% tissue culture infectious dose (TCID50)/
mL. Aliquots of viral stock were stored at −80∘C until use.
2.3. Cytotoxicity Assays. The effect of SPs on cell viability
of Vero cells was determined by MTT assay. The cells were
cultured in 96-well plates at a density of 1.5 × 104 cells/well
at 37∘C in an atmosphere of CO
2
. After 1 day of incubation,
increasing concentrations of SPs diluted in DMEM were
added; after 48 h of incubation the media were replaced with
22𝜇L of 2.5mg/mL MTT dissolved in phosphate-buffered
saline (PBS). After 1 h 30min 150 𝜇L of DMSOwas added and
incubated at room temperature for 15min.Theoptical density
(OD450 nm) was measured using a microplate reader (Mul-
tiskan FC,Thermo, USA). Cell viability was expressed by per-
centage as the mean value of three independent experiments
considering control cells absorbance as 100%viable. CC
50
was
the concentration of the test substances that inhibited the
Vero cells growth by 50% compared with the growth of the
untreated cells.
2.4. Syncytia Reduction Assays. The antiviral activity of the
SPs was evaluated by syncytia reduction assays. Vero cells
seeded in 12-well plates were treated with different concen-
trations of SPs (0.01–5𝜇g/mL) and infected with MeV (1 ×
103.5 TCID50 of Edmonston strain) at the same time. After
virus adsorption for 1 h at 37∘C the medium was removed
and monolayers were washed with PBS, after which the
corresponding concentrations of SPs were added again.
Each concentration was tested using three culture wells
per PS concentration per experiment; the experiments were
performed by triplicate. After incubation of 48 or 72 h at
37∘C in a 5% CO
2
incubator monolayers were fixed with
methanol : acetone (1 : 1) and stained with 1% crystal violet.
Syncytia were counted and the result was expressed as a per-
centage of the number of syncytia observed in viral control
monolayers (untreated cultures); IC
50
was determined from
dose-response curves. The selectivity index (SI) values were
calculated as CC
50
/IC
50
. SPs showing the best SI were selected
for the subsequent experiments.
2.5. Quantitative Real-Time PCR. Total RNA was isolated
from treated Vero cells using RNAzol RT (MRC Inc.,
USA). Reverse transcription was performed using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems, USA) and the viral genome was amplified with spe-
cific primers (MeVF: 5󸀠 GAGGGTCAAACAGAGTCGAG 3󸀠,
MeVR: 5󸀠 CGGTTGGAAGATGGGCAG 3󸀠) that amplified
a 95 nt fragment. The real-time PCR was carried out using
SensiFAST SYBR No-ROX Kit (BIOLINE, USA) and the
Chromo4 Real-Time PCR Detector (Bio-Rad, USA) with
the following procedures: 95∘C for 2min, followed by 50
cycles of 95∘C for 2 s, 60∘C for 10 s, and 72∘C for 20 s. The
number of viral copies was calculated by using a standard
curve. Serial 10-fold dilutions of a synthetic oligonucleotide
encompassing the target measles gene were used to establish
the standard curves.
2.6. Evaluation of SPs Synergy. Potential synergistic effects
of selected SPs on MeV infection were evaluated using
syncytia reduction assays. Each combination was tested on
its corresponding IC
75
, IC
50
, and IC
25
values. The synergistic
effect of SPs was calculated by using a combination index
(CI) described previously by Chou [33] and CompuSyn
software. CI was calculated from the data as a measure of the
interaction among drugs. CI values lower than 0.9 indicate
synergy, CI values from 0.9 to 1.1 indicate an additive effect,
and CI values higher than 1.1 indicate antagonism. Combina-
tions with synergistic antiviral effect were selected and qPCR
assays were performed in order to confirm the inhibitory
effect as described above.
2.7. Time of Addition Assay. Vero cell monolayers were
infected with MeV. SPs were added at a concentration of
5 𝜇g/mL at different times of infection: 60min before infec-
tion and 0, 15, 30, 60, and 120min after infection. Thereafter,
for each treatment, cells were incubated with SP for 1 h and
then washed three times with PBS. Monolayers were fixed
withmethanol : acetone after incubation for 48 or 72 h at 37∘C
and 5% CO
2
and stained with 1% crystal violet; syncytia were
counted subsequently.
2.8. Viral PenetrationAssay. Virus penetration intoVero cells
was evaluated according to the method reported by Huang
and Wagner [34] with some modifications [18]. Vero cell
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Figure 1: Confirmation of antiviral activity of Eisenia arborea (a) and Solieria filiformis (b) SPs at their best inhibitory concentrations by
syncytia reduction and qPCR assays. Syncytia count and viral RNA copies number are given in % of the untreated control values.
monolayers precooled at 4∘C for 3 h were infected with MeV
at 4∘C for 1 h in the absence of SP. After washing three times
with ice-cold PBS, different concentrations of SP were added
to the monolayers, and the temperature was shifted to 37∘C.
After 1 h of incubation at 37∘C, the cells were treated with
40mM citrate buffer (pH 3.0) to inactivate unpenetrated
viruses. Buffer was replaced by culture medium and the cells
were incubated for 48 or 72 h at 37∘C and 5%CO
2
and stained
with 1% crystal violet; syncytia were counted subsequently.
2.9. Statistical Analysis. The variables (tested by triplicate in
each experiment that were in turn repeated at least three
times) were submitted to a one-way analysis of variance
followed by Dunnett’s test (SPSS software, 𝛼 = 0.05). CC
50
and IC
50
values were determined by probit regression analy-
sis.
3. Results
3.1. Cytotoxicity and Antiviral Activity of SPs. TheMTT assay
indicated no cytotoxicity for any of the SPs at concentrations
from 0.1 to 1500 𝜇g/mL up to 2 days (data not shown).
Antiviral activity of SPs against MeV was evaluated by
syncytia reduction inhibition assays at concentrations of 0.01,
0.1, 1, and 5 𝜇g/mL of each compound (data not shown).
All tested compounds showed significant antiviral activity,
but only compounds with the best SI values were selected
for the subsequent experiments. As shown in Table 1, SPs
of Eisenia arborea and Solieria filiformis exhibited antiviral
activity at the lowest concentrations (IC
50
0.275 𝜇g/mL and
0.985 𝜇g/mL, resp.) without cytotoxic effect at concentrations
of 0.1 to 1500𝜇g/mL. Therefore, SPs of Eisenia arborea and
Solieria filiformiswere selected based on their SI and antiviral
activity for the combination experiments.
Table 1: Cytotoxic effect, antiviral activity, and selectivity index of
SPs.
Algaea CC
50
(𝜇g/mL)b IC
50
(𝜇g/mL)c SId
Macrocystis pyrifera >1500 1.00 >1500
Eisenia arborea >1500 0.275 >5454.54
Pelvetia compressa >1500 1.00 >1500
Ulva intestinalis >1500 3.6 >416.7
Solieria filiformis >1500 0.985 >1522.84
aAlgal sulfated polysaccharide extract. bConcentration of test compound
(𝜇g/mL) that reduced Vero cell viability by 50%. cConcentration of a test
compound that reduced the number of MeV syncytia in Vero cells by 50%.
dSelectivity index value.
Antiviral effect of selected SPs was confirmed by qPCR
assays, as shown in Figure 1. Inhibitory effect of Eisenia
arborea and Solieria filiformis SP was tested at the best
inhibitory concentrations (1𝜇g/mL and 5 𝜇g/mL for both
SPs). Results of qPCR assays were consistent with the results
observed by syncytia reduction inhibition assays.
3.2. Characterization of SPs. Infrared spectroscopy has been
used for the qualitative characterization of carrageenans and
has proven to be a valuable tool for the characterization
of sulfated oligosaccharides [35]. FT-IR and NMR spectra
analyses of selected SPs extracts were performed. The FT-IR
spectrum of Solieria filiformis extract (Figure 2(a)) indicates
the presence of a typical 𝜄-carrageenan type. Characteristics
signal bands are indicated: 3,6 anhydrogalactose-2-sulfate
(804 cm−1) characteristic of 𝜄-carrageenan; galactose-4-
sulfate (846 cm−1) signal present in 𝜅- and 𝜄-carrageenan.The
signal between 1210 and 1260 cm−1 is common to all types of
compounds containing sulfate.
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Figure 2: (a) Infrared spectra of (A) Solieria filiformis aqueous extract, (B) 𝜄-carrageenan, (C) 𝜅-carrageenan, and (D) 𝜆-carrageenan. (b)
Infrared spectra of (A) Eisenia arborea aqueous extract, (B) fucoidan, and (C) alginic acid.
13C-NMR spectroscopy has been highly recommended
for distinguishing the polysaccharides of the agar and car-
rageenan group [36]. Spectrum and expansion 13C-NMR of
the S. filiformis extract (Figure 3(a)) showed signals at 20
and 60 ppm typical of residual ethanol. Carbohydrates sig-
nals (63.79–104.66 ppm) observed, particularly two upfield-
shifted signals (94.51 and 104.66 ppm), suggest that the
molecule has two anomeric carbons. Overall its spectrum
showed the presence of the 𝜄-carrageenan. The next assign-
ment is the mapping of the carbon signals of the molecule.
Carbons of 2-sulfate-3,6-anhydrogalactose are 94.51 (C1),
77.44 (C2), 80.25 (C3), 80.84 (C4), 79.49 (C5), and 72.33
(C6) ppm [37]. Carbons of 4-sulfate-galactose are 104.66
(C1), 71.68 (C2), 79.27 (C3), 74.51 (C4), 77.27 (C5), and 63.79
(C6) ppm [37]. Sulfate content of S. filiformis showed 21.14%
(±0.056) of total sulfate and total polysaccharide determina-
tion resulted in 91% of polysaccharide.
The FT-IR spectrum of Eisenia arborea extract (Fig-
ure 2(b)) indicates the presence of a mixture of fucoidan
and alginic acid. Characteristics signal bands are indicated:
carboxylate vibrations (1627 and 1410 cm−1) can be attributed
to uronic acids. Stretching vibrations at 1039–1041 cm−1 can
be assigned to pyranose ring from guluronic andmannuronic
acid residues. The broad band at 1244 cm−1 indicates the
presence of sulfated ester groups, which are characteristic
in fucoidans. 13C-NMR spectrum of E. arborea extract
(Figure 3(b)) showed typical signals of alginate ranging from
66.04 to 177.68 ppm.The signal at 66.04 ppm is characteristic
of carbon-2 of guluronic acid (G) [38]. The signals at 72.51,
72.79, 74.07, 78.90, 80.82, 102.81, 102.93, and 177.68 ppm corre-
spond to repeating blocks of mannuronic (M) and guluronic
acid [39]. The signals at 102.81 and 102.93 ppm may indicate
the presence of two repeating units, one ofMMMand another
of GMM [39]. Sulfate content of E. arborea showed 12.85%
(±0.346) of total sulfate.
3.3. Combined Antiviral Effect of SPs. The combined effect
of SPs of Eisenia arborea and Solieria filiformis on MeV
infections was examined: each SP was tested at different con-
centrations combining its corresponding IC
25
, IC
50
, and IC
75
values. E
25
, E
50
, and E
75
correspond to IC
25
, IC
50
, and IC
75
values of Eisenia arborea SPs and S
25
, S
50
, and S
75
correspond
to the respective values of Solieria filiformis SP (Table 2).
Syncytia reduction assay results were expressed in relative
syncytia percentage according to the number of syncytia in
viral control. Best inhibitory effect was observed for E
50
-S
25
combination.
The evaluation of drug synergism based on a median-
effect equation has been extensively used in the literature.
CI values of SPs combinations were calculated as described
previously using the CompuSyn software and are given
in Table 2. Median-effect and the normalized isobologram
generated with the software determined the presence of three
synergistic combinations, represented by points below the
lines at normalized isobologram (Figure 4).
Results showed strong synergistic effects at low concen-
trations combinations (E
50
-S
25
, E
25
-S
50
, and E
25
-S
25
) and
antagonism at high concentrations combinations (E
25
-S
75
,
E
50
-S
50
, E
50
-S
75
, E
75
-S
25
, E
70
-S
50
, and E
75
-S
75
). Combinations
with synergistic effect were selected and qPCR assays were
performed. As shown in Figure 5 the inhibitory effect of
the synergistic combinations was confirmed. These data
were consistent with results observed by syncytia reduction
inhibition assays.
3.4. Effect of SPs on Viral Infection at Different Times of
Addition. In order to determine which step of the MeV cycle
was targeted by SPs, “time of addition” experiments were
performed in Vero cells infected withMeV and exposed to PS
at different times of infection.Themost efficient inhibition by
S. filiformis was observed in early phases of infection, 0 and
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Figure 3: (a) Spectrum and expansion 13C-NMR of the aqueous extract of S. filiformis. (b) 13C-NMR spectrum of the aqueous extract of E.
arborea.
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Table 2: Synergistic effects of SPs on MeV infection.
Compounds
combination
Compound concentration (𝜇g/mL) % relative syncytia formation in presence of
the different SPs combinations SD CI DescriptionEisenia arborea Solieria filiformis
IC
75
-IC
75
2.98 3.027 34.5 4.4 10.59 Antagonism
IC
75
-IC
50
2.98 0.985 26.4 5.6 3.08 Antagonism
IC
75
-IC
25
2.98 0.011 33 7.3 1.47 Antagonism
IC
50
-IC
75
0.275 3.027 28.4 4.1 3.71 Antagonism
IC
50
-IC
50
0.275 0.985 32 5.9 1.88 Antagonism
IC
50
-IC
25
0.275 0.011 4 3.2 0.001 Synergism
IC
25
-IC
75
0.01 3.027 22.5 6.6 1.85 Antagonism
IC
25
-IC
50
0.01 0.985 16.7 7.1 0.31 Synergism
IC
25
-IC
25
0.01 0.011 39.4 2.5 0.05 Synergism
2
−2
−2
2
Sf
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Figure 4: Analysis of Eisenia arborea and Solieria filiformis combinations. (a) Median-effect plot for combinations of Eisenia arborea and
Solieria filiformis was generated with the CompuSyn software (𝐹
𝑎
, affected fraction; 𝐹
𝑢
, unaffected fraction; 𝐷, concentration of SP used; Sf
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for Sf and Ea at nonconstant combination ratios. For each SP different combinations of various concentrations based on IC
25
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values
were tested and combination index (CI) values were determined using the CompuSyn software. CI values, represented by points below the
lines, indicate synergy.
15min after infection (Figure 6); syncytia inhibition before
infection and 30min after infection was not significant. E.
arborea showed the most efficient inhibition 1 hour before
infection and 0 and 15min after infection. At 30, 60, and
120min after infection, a minimal syncytia inhibition by E.
arborea was still observed.
3.5. Effect of Fucoidan on Viral Penetration into Host Cells.
Viral penetration assays were performed to determine
whether entry events downstream of virus binding were
inhibited by SPs. Vero cells were plated and incubated with
MeV at 4∘C for 1 h to allow virus binding but prevent viral
internalization. Unbound virus was inactivated and SPs
(1 𝜇g/mL or 5𝜇g/mL) were added to the cells and incubated
at 37∘C. Figure 7 shows that SP from S. filiformis (5 𝜇g/mL)
significantly decreased viral infection by 58%, while SPs from
E. arborea (5 𝜇g/mL) decreased viral infection only by 24%,
when compared with the findings in infected cells in the
absence of treatment.
4. Discussion
Since the first studies by Gerber in 1958 showing the inhi-
bition of mumps and influenza B virus by marine algae
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Figure 6: Time of addition experiments. Antiviral activity of SP
was tested at different times of infection and analyzed by syncytia
inhibition assays. SPs were added at 60min before infection and
0, 15, 30, 60, and 120min after infection. The data are expressed
as relative syncytia count (%) compared to that of untreated virus-
infected control cells, which was defined as 100%. The data shown
are the mean ± SD of triplicate experiments.
polysaccharides, increased efforts and research have been
carried out in this field [13]. Previous studies have also
demonstrated no cytotoxicity of SPs isolated fromcertain sea-
weed species [40].The absence of cytotoxicity to the host cells
is one of the principal challenges in the development of new
antivirals.
Eisenia arborea, an edible brown alga used in folk
medicine in Japan, is the kelp species with the largest and
most southerly latitudinal distribution on the North Pacific
East Coast [41, 42]. Researches on Eisenia biological activities
have been focused on the evaluation of their polyphenolic
compounds [43]. To our knowledge, the antiviral effects of
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Figure 7: Effect of SPs on viral penetration. Vero cells were infected
with MeV at 4∘C in the absence of SPs and then shifted to 37∘C
to permit penetration of the adsorbed virus in the presence of SPs.
Antiviral effect of SPs was evaluated using syncytia inhibition assays.
The data shown are the mean ± SD of triplicate experiments.
Eisenia arborea extracts have never been tested before. In
this study, the extract of Eisenia arborea is rich in fucoidans
and alginates and also showed the best SI of the five seaweed
extracts (Table 1). Previous chemical characterization of
Mexican E. arborea extracts also reported the presence of
alginates, with higher yields than the one reported in this
study [44]. Alginates with antiviral effects have been previ-
ously tested against HIV, IAV, and HBV, showing a potent
antiviral activity [4]. Antiviral activity of fucoidan has been
also reported in vitro and in vivo againstmanyRNA andDNA
viruses such as HIV, HSV1-2, dengue virus, and influenza
virus [39, 45–47].
Macrocystis pyrifera has been harvested since 1956 along
the Pacific coast of Baja California and exported to theUnited
States for the production of alginates [48]. SPs extracts of
Mexican Macrocystis pyrifera showed a significant antiviral
effect but were not selected for subsequent assays because
of their IC
50
value (Table 1). Previous studies with crude
dialyzed extracts ofMacrocystis pyrifera have shown antiviral
effects against VSV, with the fucoidan being responsible for
these results [49].
In this study, antiviral effects of the extract from Solieria
filiformis display the second lowest IC
50
among the analyzed
extracts. In vitro studies have reported antiviral properties of
carrageenans againstDNAandRNAviruses [21, 50]. Recently
it has been shown that carrageenan (Rong Yuan F.F.I. Co.,
Ltd.) can inhibit influenza virusA/Swine/Shandong/731/2009
H1N1 (SW731) responsible for the influenza pandemic of
2009. Carrageenans can significantly inhibit SW731 replica-
tion by interfering with different steps of viral replication,
including adsorption, transcription, and expression of the
viral proteins; however, they act especially by inhibiting the
interactions between the viral receptor (HA) and the target
cell [51]. Sulfate content analysis and total polysaccharide
determination of S. filiformis extract resulted in 21.14%
(±0.056) total sulfate and 91% polysaccharide; these data are
consistent with previous reports [52]. Degree of sulfation has
a major impact on the antiviral activity of polysaccharides,
including carrageenans [53].
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In relation to the combination therapy approach used
in this study, results showed a strong synergistic effect at
low concentrations combinations of SPs and antagonism at
high concentrations combinations. Our results determined
that low concentrations combinations (0.0274 𝜇g/mL and
0.011 𝜇g/mL of E. arborea and S. filiformis, resp.) exhibited
the higher inhibitory effect (96%) in comparison to the indi-
vidual effect of SP (50% of inhibition with 0.275𝜇g/mL and
0.985 𝜇g/mL of E. arborea and S. filiformis, resp.). Synergistic
effect observed in this study has been also reported for the
sulfated polysaccharides from Fucus vesiculosus in combina-
tion with AZT against HIV [54]. Furthermore, this effect has
been also observed with acyclovir in combination with 3, 19-
isopropylideneandrographolide against herpes simplex virus
(wild type) and drug-resistant strains. Low concentrations
of these compounds were required for a complete inhibition
of DNA replication and late protein synthesis of HSV-1 wild
type and drug-resistant HSV-1 [55]. The combined effect of
nitazoxanidewith neuraminidase inhibitors against influenza
A viruses tested in vitro suggests that regimens that combine
neuraminidase inhibitors and nitazoxanide exert synergistic
anti-influenza effects [56]. In contrast, antagonistic effects
at high concentrations were observed in our study; this
antagonism of SPs was previously observed in a combination
of ulvan and fucoidan against NDV infection [23]. Partic-
ular chemical features of SPs like chain ramifications could
explain antagonism effects of SPs. Moreover, carbohydrate to
carbohydrate interactions could be responsible to adhesion
events; these aggregates have been previously observed in
marine sponges [57].
To understand if a synergistic effect was related to differ-
ent modes of action of the tested SPs, viral penetration and
time of addition assays were performed. Results suggested
the possibility that SP from S. filiformis inhibits postbinding
events, because best inhibition effect was observed at 0 and 15
minutes after viral infection (Figure 6). To support this idea, a
viral penetration assay was performed (Figure 7), and results
show the best antiviral effect after viral adsorption. Our
results are in agreement with those observed by Elizondo-
Gonzalez et al. [18], who demonstrated the ability of fucoidan
fromC. okamuranus to be responsible for the antiviral activity
against Newcastle disease virus, suggesting that fucoidan
inhibits viral penetration into host cells, must probably by
blocking the F protein.
Similar results were also observed by Bouhlal et al. [58],
who suggested that carrageenans can inhibit DENV repli-
cation by interfering viral entrance, but they also suggested
that SPs could avoid viral adsorption into the cell as a second
mode of action. This mode of action could be similar to the
mechanism observed with SPs of E. arborea. Alginates and
fucoidan of E. arborea were able to show the best antiviral
effect 1 hour before infection and this effect lasted up to 0–15
minutes after infection. Although both SPs, from S. filiformis
and E. arborea, exhibited antiviral activity at 0 and 15min
after infection, only E. arborea showed inhibitory effect at
60min.This result suggests the capability of these SPs to avoid
viral adsorption to the cell; these data were confirmed by viral
penetration assays where we observed less antiviral activity
after viral attachment to the cell. More recent studies have
demonstrated that fucoidans exhibit their antiviral activity
when the compound is present during the virus adsorption
period by blocking the interaction of viruses to the cells [59].
SPs tested in this study exhibit the best antiviral effect
at different stages of infection: viral penetration and viral
adsorption (S. filiformis and E. arborea, resp.). Multiple-drug
antiviral therapy with two or more drugs that target different
proteins or act in different stages of infection may decrease
drug resistance and may enhance clinical outcomes by
allowing a reduction of individual drug doses, thus decreas-
ing dose-related drug toxicity [60].
5. Conclusions
In this study sulfated polysaccharides from Mexican sea-
weed showed antiviral activity against measles virus. Due
to the lack of cytotoxicity at inhibitory concentrations, as
indicated by the selectivity index, potential application can
be found for these SPs. Eisenia arborea and Solieria filiformis
extracts showed the higher antiviral activity andwere selected
to determine their combined effect. Synergistic effect was
observed at the lowest concentrations tested for each SP of
these species. Results suggest that SPs combined in this study
are acting at different level of first stages in viral infection.
Synergistic therapeutic effect allows dose and toxicity reduc-
tion and would minimize or delay the induction of antiviral
resistance. Sulfated polysaccharides of Mexican seaweed are
potential candidates for the development of new antiviral
drugs that can help to control viral infection diseases.
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